查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1717774

空間基因組學和轉錄組學市場（按產品、定序方法、應用和最終用戶）—2025-2030 年全球預測

Spatial Genomics & Transcriptomics Market by Product, Sequencing Method, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

空間基因組學和轉錄組學市場預計在 2023 年價值 10.5 億美元，在 2024 年達到 11.8 億美元，並以 12.35% 的複合年成長率成長，到 2030 年達到 23.8 億美元。

主要市場統計數據
基準年2023年 10.5億美元
預計2024年 11.8億美元
預測年份 2030 23.8億美元
複合年成長率（%） 12.35%

空間基因組學和轉錄組學已成為生命科學的關鍵領域，重新定義了我們對細胞功能和組織結構的理解。成像、定序和計算數據分析的進步匯聚在一起，創造了一門變革性學科，其中空間背景在闡明複雜的生物現像中發揮關鍵作用。這項新模式正在刺激投資增加、擴大研究視野並鼓勵專家之間的跨學科合作。在技​​術突破和對人體和疾病機制的深入了解的不斷追求的推動下，該領域正在迅速發展成為精準醫療的基石。目前的情況為診斷檢測、藥物發現和標靶治療的創新提供了良好的機會，為全面探索其對醫療保健和研究的影響奠定了基礎。隨著該領域的加速發展，研究人員和決策者必須掌握既定原則和新興趨勢，以發揮空間生物學的潛力。

改變空間基因組學和轉錄組學市場

近年來，空間基因組學和轉錄組學領域發生了變革性的變化。技術進步促進了新的定序平台和成像技術的發展，提供了前所未有的解析度和效率。人們正在從傳統的批量分析轉向單細胞和基於空間的研究，這正在重新定義實驗設計和數據解釋。這些變化體現在跨學科合作推動的快速技術創新。計算工具和數據分析的進步使研究人員能夠破解組織內的複雜空間關係，增強我們理解細胞網路內基因表現的空間編配的能力。這種動態環境預示著一個新時代的到來，精準技術不僅將加強研究，還將推動個人化治療和診斷的發展。公司、學術團體和臨床研究機構正在加大對這些方法的投資，以在競爭激烈的研究領域中保持領先地位，因此產業相關人員必須從策略上適應這些變革趨勢。

關鍵細分洞察

對空間基因組學和轉錄組學細分框架的詳細分析揭示了由多種因素塑造的多面向市場模式。以產品維度為關鍵軸，將市場分解為耗材、設備和軟體。在檢測試劑套件和試劑的背景下對耗材部分進行了研究，在高精度分子工具需求的推動下，耗材部分呈現強勁成長。同時，設備部分包括尖端顯微鏡和定序平台，它們對於實現空間分析的高解析度至關重要。此外，數據分析平台和視覺化工具等軟體解決方案在解釋複雜資料集方面發揮著至關重要的作用。原位定序、多重抗誤差螢光原位雜合技術、連續式螢光原位雜合技術、Slide-seq 和空間轉錄組學等方法提供了獨特的能力和分析可能性。在考慮應用時，研究重點包括癌症研究（包括腫瘤學分析和腫瘤微環境分析的詳細評估）到發育生物學、藥物發現、免疫學和神經病學。例如，在藥物研發中，生物標記分析和治療標靶識別已成為關鍵的研究驅動力。此外，按最終用戶細分，可以發現受眾範圍廣泛，從細分為生物部門和基因組學中心等專門單位的學術研究機構，到臨床研究機構、製藥公司、生物技術公司和研究實驗室（包括核心設施和私人實驗室）。綜合起來，這些細分揭示了市場成熟度的水平，每個細分都為研究、技術和目標應用的生態系統做出了貢獻。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 慢性病盛行率的上升推動了先進空間基因組解決方案的需求。
      • 空間基因組學和轉錄組學在個人化醫療的應用日益增多
      • 早期檢測和診斷的重要性日益增加，推動了空間基因組學的創新
    • 限制因素
      • 在合理時限內取得高解析度空間資料的局限性
    • 機會
      • 顯微鏡和成像技術的進步提高了基因組學研究的空間解析度和精度。
      • 增加基因組學調查的資金將刺激空間轉錄組學研究的發展
    • 任務
      • 基因和單細胞定序的報銷差異和不確定性
  • 市場區隔分析
    • 產品：高通量和高準確度正在推動實驗室中檢測試劑套件的使用增加
    • 定序方法：使用具有高解析度基因表現空間圖的幻燈片定序提供了重要的見解。
    • 應用：採用空間基因組學加速藥物發現與開發
    • 最終用戶：優先考慮臨床研究機構，提高臨床試驗的準確性
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

6. 空間基因體學和轉錄組學市場（按產品）

  • 耗材
    • 檢測試劑套件
    • 試劑
  • 裝置
    • 顯微鏡
    • 定序平台
  • 軟體
    • 數據分析平台
    • 視覺化工具

7. 空間基因體學和轉錄組學市場（按定序方法）

  • 原位定序
  • 多重誤差穩健螢光雜合反應
  • 常規螢光原位雜合反應
  • 幻燈片序列
  • 空間轉錄組學

8. 空間基因體學和轉錄組學市場（按應用）

  • 癌症研究
    • 腫瘤學分析
    • 腫瘤微環境分析
  • 發育生物學
  • 藥物研發
    • 生物標記分析
    • 確定治療目標
  • 免疫學
  • 神經病學

9. 空間基因體學和轉錄組學市場（按最終用戶）

  • 學術研究所
    • 生物系
    • 基因組學中心
  • 臨床研究所
  • 製藥和生物技術公司
  • 研究部門
    • 核心設施
    • 私人實驗室

10.美洲空間基因體學和轉錄組學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

11. 亞太地區空間基因體學與轉錄組學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

12. 歐洲、中東和非洲太空基因體學和轉錄組學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023年市場佔有率分析
  • 2023年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Akoya Biosciences, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Bruker Corporation
  • Carl Zeiss AG
  • Danaher Corporation
  • Evident Corporation
  • Illumina, Inc.
  • Indica Labs, Inc.
  • Ionpath, Inc.
  • Merck KGaA
  • Parse Biosciences
  • PerkinElmer, Inc.
  • RareCyte, Inc.
  • Rebus Biosystems, Inc.
  • Resolve Biosciences GmbH.
  • S2 Genomics, Inc.
  • Seven Bridges Genomics
  • Standard BioTools Inc.
  • Thermo Fisher Scientific Inc.
  • Ultivue, Inc.
  • Vizgen Inc.
Product Code: MRR-F611BFBC5D35

The Spatial Genomics & Transcriptomics Market was valued at USD 1.05 billion in 2023 and is projected to grow to USD 1.18 billion in 2024, with a CAGR of 12.35%, reaching USD 2.38 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 1.05 billion
Estimated Year [2024] USD 1.18 billion
Forecast Year [2030] USD 2.38 billion
CAGR (%) 12.35%

Spatial genomics and transcriptomics have emerged as pivotal areas in life sciences, redefining our understanding of cellular function and tissue architecture. Advances in imaging, sequencing, and computational data analysis have converged to create a transformative discipline, where spatial context plays a critical role in elucidating complex biological phenomena. This new paradigm has fueled increased investments, broadened research horizons, and inspired cross-disciplinary collaboration among experts. Driven by technological breakthroughs and an insatiable quest for deeper insights into the human body and disease mechanisms, this field is rapidly evolving into a cornerstone of precision medicine. The present landscape offers promising opportunities for innovation in diagnostic assays, drug discovery, and targeted therapies, setting the stage for a comprehensive exploration of its impact on medicine and research. As the field accelerates, researchers and decision-makers must navigate both established principles and emerging trends to capitalize on the potential of spatial biology.

Transformative Shifts in the Landscape

Recent years have witnessed transformative shifts within the spatial genomics and transcriptomics arena. Technological evolution has spurred the development of new sequencing platforms and imaging techniques that offer unprecedented resolution and efficiency. An ongoing transition is underway from traditional bulk analyses to single-cell and spatially informed studies, a shift that is redefining experimental design and data interpretation. These changes are underscored by rapid innovation driven by interdisciplinary collaboration. Advances in computational tools and data analytics are now enabling researchers to decode complex spatial relationships in tissues, thus enhancing our ability to understand the spatial orchestration of gene expression within cellular networks. This dynamic environment is heralding a new era where precision techniques not only bolster research but also foster the development of personalized therapies and diagnostics. Enterprises, academicians, and clinical research organizations are increasingly investing in these methodologies to stay ahead in a competitive research landscape, making it imperative for industry stakeholders to adapt strategically to these transformative trends.

Key Segmentation Insights

A detailed analysis of the segmentation framework in spatial genomics and transcriptomics reveals a multi-faceted market landscape shaped by diverse factors. With the product dimension as a crucial axis, the market dissects into consumables, instruments, and software. The consumables segment, studied in the context of assay kits and reagents, demonstrates robust growth driven by demand for high-precision molecular tools. In parallel, the instruments segment encompasses state-of-the-art microscopes and sequencing platforms that are essential for achieving high resolution in spatial analysis. Additionally, software solutions, including data analysis platforms and visualization tools, play an indispensable role in interpreting complex datasets. The evolution of sequencing methodologies further enriches segmentation; approaches such as in situ sequencing, multiplexed error-robust fluorescence in situ hybridization, sequential fluorescence in situ hybridization, Slide-seq, and spatial transcriptomics offer distinct capabilities and analysis potential. When considering applications, research focuses span from cancer research-which includes detailed evaluations in oncology profiling and tumor microenvironment analysis-to developmental biology, drug discovery, immunology, and neurology. In drug discovery, for example, biomarker analysis and therapeutic target identification are emerging as key research drivers. Furthermore, segmentation by end-user highlights audiences ranging from academic research institutions, subdivided into specialized bodies such as biology departments and genomics centers, to clinical research organizations, pharmaceutical and biotechnology companies, and research laboratories that include core facilities along with private labs. Collectively, these segmentation insights underline the level of sophistication present in the market, where each segment contributes to an interwoven ecosystem of research, technology, and targeted application.

Based on Product, market is studied across Consumables, Instruments, and Software. The Consumables is further studied across Assay Kits and Reagents. The Instruments is further studied across Microscopes and Sequencing Platforms. The Software is further studied across Data Analysis Platforms and Visualization Tools.

Based on Sequencing Method, market is studied across In Situ Sequencing, Multiplexed Error-Robust Fluorescence In Situ Hybridization, Sequential Fluorescence In Situ Hybridization, Slide-seq, and Spatial Transcriptomics.

Based on Application, market is studied across Cancer Research, Developmental Biology, Drug Discovery, Immunology, and Neurology. The Cancer Research is further studied across Oncology Profiling and Tumor Microenvironment Analysis. The Drug Discovery is further studied across Biomarker Analysis and Therapeutic Target Identification.

Based on End-User, market is studied across Academic Research Institutions, Clinical Research Organizations, Pharmaceutical & Biotechnology Companies, and Research Laboratories. The Academic Research Institutions is further studied across Biology Departments and Genomics Centers. The Research Laboratories is further studied across Core Facilities and Private Labs.

Key Regional Insights

Geographical trends play a significant role in shaping the spatial genomics and transcriptomics market. In the Americas, a robust network of leading research institutions and a strong focus on precision medicine are driving innovations and adoption. The Europe, Middle East & Africa region sees a confluence of traditional academic excellence and rapidly expanding industrial research, where regulatory frameworks and cross-border collaborations are facilitating advanced studies. Meanwhile, in the Asia-Pacific, dynamic economic growth and substantial investments in biotechnology are fueling rapid market expansion, making it a focal point for transformative research initiatives. These regions collectively provide a heterogeneous landscape of research capabilities and investment opportunities, representing both mature markets and fast-growing territories within the global spatial biology arena. As these regions continue to evolve, strategic geographical insights are essential for aligning research investments with local expertise and global trends.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights

Industry leaders are spearheading innovation in spatial genomics and transcriptomics through strategic investments in research and technology development. Prominent companies such as 10x Genomics, Inc. and Agilent Technologies, Inc. are pushing the boundaries by introducing state-of-the-art instruments and consumables that enable unparalleled analytical precision. Akoya Biosciences, Inc. and Becton, Dickinson and Company have become key players by offering comprehensive imaging and diagnostic solutions, while Bio-Rad Laboratories, Inc. and Bio-Techne Corporation continue to enrich the market with high-quality assay kits and reagents. Bruker Corporation and Carl Zeiss AG consolidate their positions by delivering advanced microscopy systems, and Danaher Corporation along with Evident Corporation are renowned for their robust contribution to cutting-edge analytical tools. Illumina, Inc. and Indica Labs, Inc. have set benchmarks in high-throughput sequencing and data management, and innovative solutions from Ionpath, Inc. and Merck KGaA further highlight the competitive spirit in the market. Emerging leaders such as Parse Biosciences, PerkinElmer, Inc., RareCyte, Inc., Rebus Biosystems, Inc., Resolve Biosciences GmbH., S2 Genomics, Inc., Seven Bridges Genomics, Standard BioTools Inc., Thermo Fisher Scientific Inc., Ultivue, Inc., and Vizgen Inc. drive the competitive landscape by constantly exploring new technological frontiers. These companies collectively underscore the market's diverse and competitive ecosystem, where strategic partnerships and continuous innovation are keys to maintaining leadership in this rapidly evolving field.

The report delves into recent significant developments in the Spatial Genomics & Transcriptomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., Akoya Biosciences, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Bruker Corporation, Carl Zeiss AG, Danaher Corporation, Evident Corporation, Illumina, Inc., Indica Labs, Inc., Ionpath, Inc., Merck KGaA, Parse Biosciences, PerkinElmer, Inc., RareCyte, Inc., Rebus Biosystems, Inc., Resolve Biosciences GmbH., S2 Genomics, Inc., Seven Bridges Genomics, Standard BioTools Inc., Thermo Fisher Scientific Inc., Ultivue, Inc., and Vizgen Inc.. Actionable Recommendations for Industry Leaders

Industry leaders should invest in robust cross-disciplinary research collaborations and foster technology partnerships to secure a competitive edge in the spatial genomics and transcriptomics landscape. It is essential to channel resources into state-of-the-art instrumentation and advanced computational analytics, ensuring that new methodologies drive both speed and accuracy in research efforts. Companies must establish agile operational frameworks that allow for rapid adaptation to technological breakthroughs and evolving market paradigms. Auditing current research portfolios and aligning them with emerging trends will enable a seamless transition into areas with high growth potential, particularly in personalized medicine and precision diagnostic platforms. A proactive stance on regulatory compliance and intellectual property management is critical in maintaining market integrity and safeguarding innovations. Furthermore, nurturing talent through strategic training programs and in-house research initiatives will not only drive internal innovation but also solidify partnerships with external academic and clinical institutions. Overall, this multi-pronged approach will position industry stakeholders to successfully navigate the evolving market dynamics and fully capitalize on the transformative potential of spatial genomics and transcriptomics.

Conclusion: A Vision for Future Growth

In conclusion, the landscape of spatial genomics and transcriptomics is poised to unlock unprecedented research opportunities and applications across medicine and biology. The integration of innovative instruments with advanced software solutions and diverse sequencing methodologies is setting new standards in research precision and diagnostic accuracy. Strategic segmentation by product, sequencing method, application, and end-user highlights a complex yet dynamic market structure that caters to various scientific and healthcare needs. Coupled with significant regional and corporate insights, the stage is set for transformative growth driven by relentless innovation and collaborative ingenuity. The future of spatial genomics stands as a testament to the power of next-generation technologies, offering industry leaders a promising horizon to enhance investments and expand their influence in biomedical research.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic diseases drives demand for advanced spatial genomic solutions
      • 5.1.1.2. Increasing applications of spatial genomics and transcriptomics in personalized medicine
      • 5.1.1.3. Growing emphasis on early detection and diagnosis fueling innovations in spatial genomics
    • 5.1.2. Restraints
      • 5.1.2.1. Limitations in capturing high-resolution spatial data within reasonable timeframes
    • 5.1.3. Opportunities
      • 5.1.3.1. Developments in microscopy and imaging techniques enhancing spatial resolution and accuracy in genomics studies
      • 5.1.3.2. Increased funding for genomics research boosting developments in spatial transcriptomics studies
    • 5.1.4. Challenges
      • 5.1.4.1. Reimbursement inconsistency and uncertainty in gene & single-cell sequencing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing usage for assay kits in laboratories due to their high throughput and accuracy
    • 5.2.2. Sequencing Method: Utilization of slide-seq due to high-resolution spatial maps of gene expression, providing critical insights
    • 5.2.3. Application: Adoption of spatial genomics in accelerating drug discovery and development
    • 5.2.4. End-User: Preference for clinical research organizations enhancing precision in clinical trials
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Spatial Genomics & Transcriptomics Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Assay Kits
    • 6.2.2. Reagents
  • 6.3. Instruments
    • 6.3.1. Microscopes
    • 6.3.2. Sequencing Platforms
  • 6.4. Software
    • 6.4.1. Data Analysis Platforms
    • 6.4.2. Visualization Tools

7. Spatial Genomics & Transcriptomics Market, by Sequencing Method

  • 7.1. Introduction
  • 7.2. In Situ Sequencing
  • 7.3. Multiplexed Error-Robust Fluorescence In Situ Hybridization
  • 7.4. Sequential Fluorescence In Situ Hybridization
  • 7.5. Slide-seq
  • 7.6. Spatial Transcriptomics

8. Spatial Genomics & Transcriptomics Market, by Application

  • 8.1. Introduction
  • 8.2. Cancer Research
    • 8.2.1. Oncology Profiling
    • 8.2.2. Tumor Microenvironment Analysis
  • 8.3. Developmental Biology
  • 8.4. Drug Discovery
    • 8.4.1. Biomarker Analysis
    • 8.4.2. Therapeutic Target Identification
  • 8.5. Immunology
  • 8.6. Neurology

9. Spatial Genomics & Transcriptomics Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic Research Institutions
    • 9.2.1. Biology Departments
    • 9.2.2. Genomics Centers
  • 9.3. Clinical Research Organizations
  • 9.4. Pharmaceutical & Biotechnology Companies
  • 9.5. Research Laboratories
    • 9.5.1. Core Facilities
    • 9.5.2. Private Labs

10. Americas Spatial Genomics & Transcriptomics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Spatial Genomics & Transcriptomics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Spatial Genomics & Transcriptomics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Vizgen launch CSP program to broaden single-cell spatial genomics access
    • 13.3.2. Complete Genomics announces exclusive agreement with STOmics spatial transcriptomics and launches spatial Xcellerator grant
    • 13.3.3. Vizgen and Ultivue announce merger to propel innovation in spatial genomics and proteomics
    • 13.3.4. Lunaphore partners with Discovery Life Sciences to bring innovative spatial biology solutions to clinical research
    • 13.3.5. Deerfield proposes acquisition of Singular Genomics to enhance strategic growth in genomics and multiomics technologies
    • 13.3.6. Moleculent secures USD 26 million in series A funding to propel innovations in spatial genomics and transcriptomics
    • 13.3.7. Bruker acquires NanoString spatial biology business to enhance genomic solutions
    • 13.3.8. 10x Genomics launch Visium HD for advanced single cell-scale spatial transcriptome analysis
    • 13.3.9. DNAnexus and Curio Bioscience collaborate to enhance data analysis for spatial transcriptomics projects
    • 13.3.10. Singular Genomics launches G4X spatial sequencer to enhancing multiomic analysis efficiency
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. Becton, Dickinson and Company
    • 13.4.2. Agilent Technologies, Inc.
    • 13.4.3. Bruker Corporation
    • 13.4.4. 10x Genomics, Inc.

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Akoya Biosciences, Inc.
  • 4. Becton, Dickinson and Company
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Bio-Techne Corporation
  • 7. Bruker Corporation
  • 8. Carl Zeiss AG
  • 9. Danaher Corporation
  • 10. Evident Corporation
  • 11. Illumina, Inc.
  • 12. Indica Labs, Inc.
  • 13. Ionpath, Inc.
  • 14. Merck KGaA
  • 15. Parse Biosciences
  • 16. PerkinElmer, Inc.
  • 17. RareCyte, Inc.
  • 18. Rebus Biosystems, Inc.
  • 19. Resolve Biosciences GmbH.
  • 20. S2 Genomics, Inc.
  • 21. Seven Bridges Genomics
  • 22. Standard BioTools Inc.
  • 23. Thermo Fisher Scientific Inc.
  • 24. Ultivue, Inc.
  • 25. Vizgen Inc.

LIST OF FIGURES

  • FIGURE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET MULTI-CURRENCY
  • FIGURE 2. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET MULTI-LANGUAGE
  • FIGURE 3. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET RESEARCH PROCESS
  • FIGURE 4. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY VISUALIZATION TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IN SITU SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MULTIPLEXED ERROR-ROBUST FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENTIAL FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SLIDE-SEQ, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ONCOLOGY PROFILING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TUMOR MICROENVIRONMENT ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY BIOMARKER ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY THERAPEUTIC TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY BIOLOGY DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY GENOMICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CORE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRIVATE LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 91. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 102. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 115. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 132. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 136. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 140. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 142. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 143. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 144. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 145. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 147. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 148. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 150. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 151. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 153. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 154. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 155. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 156. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 158. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 159. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 161. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 162. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 164. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 165. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 166. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 167. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 169. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 170. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 172. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 173. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 175. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 176. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 177. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 178. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 180. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 181. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 183. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 184. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 186. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 187. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 188. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 189. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 191. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 192. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 194. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 198. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 200. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 202. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 205. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 206. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 208. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 209. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 210. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 211. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 213. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 214. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 216. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 220. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 222. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 224. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 225. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 227. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 228. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 230. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 231. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 232. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 233. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 235. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 236. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 238. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 239. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 241. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 242. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 243. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 244. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 246. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 247. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 249. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 250. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 251. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 252. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 253. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 254. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 255. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 257. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 258. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 260. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 273. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 275. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 276. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 277. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 278. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 280. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 281. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
  • TABLE 283. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 284. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 285. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 286. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 287. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 288. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
  • TABLE 289. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 291. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 292. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 293. EGYPT SPATIAL GENOMICS & TRANS